212 related articles for article (PubMed ID: 32285013)
1. The need for a system view to regulate artificial intelligence/machine learning-based software as medical device.
Gerke S; Babic B; Evgeniou T; Cohen IG
NPJ Digit Med; 2020; 3():53. PubMed ID: 32285013
[TBL] [Abstract][Full Text] [Related]
2. Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies.
Zinchenko VV; Arzamasov KM; Chetverikov SF; Maltsev AV; Novik VP; Akhmad ES; Sharova DE; Andreychenko AE; Vladzymyrskyy AV; Morozov SP
Sovrem Tekhnologii Med; 2022; 14(5):15-23. PubMed ID: 37181834
[TBL] [Abstract][Full Text] [Related]
3. Changes in software as a medical device based on artificial intelligence technologies.
Zinchenko V; Chetverikov S; Akhmad E; Arzamasov K; Vladzymyrskyy A; Andreychenko A; Morozov S
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1969-1977. PubMed ID: 35691995
[TBL] [Abstract][Full Text] [Related]
4. Technology-Enabled, Evidence-Driven, and Patient-Centered: The Way Forward for Regulating Software as a Medical Device.
Carolan JE; McGonigle J; Dennis A; Lorgelly P; Banerjee A
JMIR Med Inform; 2022 Jan; 10(1):e34038. PubMed ID: 35084352
[TBL] [Abstract][Full Text] [Related]
5. Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study.
Smith JA; Abhari RE; Hussain Z; Heneghan C; Collins GS; Carr AJ
BMJ Open; 2020 Oct; 10(10):e039969. PubMed ID: 33055121
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device.
Prabhakar B; Singh RK; Yadav KS
Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence and Machine Learning Applied at the Point of Care.
Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM
Front Pharmacol; 2020; 11():759. PubMed ID: 32625083
[TBL] [Abstract][Full Text] [Related]
8. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
Clark P; Kim J; Aphinyanaphongs Y
JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
[TBL] [Abstract][Full Text] [Related]
9. Learning with an evolving medicine label: how artificial intelligence-based medication recommendation systems must adapt to changing medication labels.
Dickinson H; Feifel J; Muylle K; Ochi T; Vallejo-Yagüe E
Expert Opin Drug Saf; 2024 May; 23(5):547-552. PubMed ID: 38597245
[TBL] [Abstract][Full Text] [Related]
10. Foundational Considerations for Artificial Intelligence Using Ophthalmic Images.
Abràmoff MD; Cunningham B; Patel B; Eydelman MB; Leng T; Sakamoto T; Blodi B; Grenon SM; Wolf RM; Manrai AK; Ko JM; Chiang MF; Char D;
Ophthalmology; 2022 Feb; 129(2):e14-e32. PubMed ID: 34478784
[TBL] [Abstract][Full Text] [Related]
11. FDA Review of Radiologic AI Algorithms: Process and Challenges.
Zhang K; Khosravi B; Vahdati S; Erickson BJ
Radiology; 2024 Jan; 310(1):e230242. PubMed ID: 38165243
[TBL] [Abstract][Full Text] [Related]
12. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
Zhu S; Gilbert M; Chetty I; Siddiqui F
Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
[TBL] [Abstract][Full Text] [Related]
13. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
Woo JH; Kim EC; Kim SM
Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence as a medical device in radiology: ethical and regulatory issues in Europe and the United States.
Pesapane F; Volonté C; Codari M; Sardanelli F
Insights Imaging; 2018 Oct; 9(5):745-753. PubMed ID: 30112675
[TBL] [Abstract][Full Text] [Related]
15. Conceptualising Artificial Intelligence as a Digital Healthcare Innovation: An Introductory Review.
Arora A
Med Devices (Auckl); 2020; 13():223-230. PubMed ID: 32904333
[TBL] [Abstract][Full Text] [Related]
16. ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: REGULATIVE ISSUES AND PERSPECTIVES.
Pashkov VM; Harkusha AO; Harkusha YO
Wiad Lek; 2020; 73(12 cz 2):2722-2727. PubMed ID: 33611272
[TBL] [Abstract][Full Text] [Related]
17. Minimum labelling requirements for dermatology artificial intelligence-based Software as Medical Device (SaMD): A consensus statement.
Ingvar Å; Oloruntoba A; Sashindranath M; Miller R; Soyer HP; Guitera P; Caccetta T; Shumack S; Abbott L; Arnold C; Lawn C; Button-Sloan A; Janda M; Mar V
Australas J Dermatol; 2024 May; 65(3):e21-e29. PubMed ID: 38419186
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence in medical device software and high-risk medical devices - a review of definitions, expert recommendations and regulatory initiatives.
Fraser AG; Biasin E; Bijnens B; Bruining N; Caiani EG; Cobbaert K; Davies RH; Gilbert SH; Hovestadt L; Kamenjasevic E; Kwade Z; McGauran G; O'Connor G; Vasey B; Rademakers FE
Expert Rev Med Devices; 2023 Jun; 20(6):467-491. PubMed ID: 37157833
[TBL] [Abstract][Full Text] [Related]
19. Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.
Farah L; Davaze-Schneider J; Martin T; Nguyen P; Borget I; Martelli N
Artif Intell Med; 2023 Jun; 140():102547. PubMed ID: 37210155
[TBL] [Abstract][Full Text] [Related]
20. The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics.
Beckers R; Kwade Z; Zanca F
Phys Med; 2021 Mar; 83():1-8. PubMed ID: 33657513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
